Suh EY - Search Results

1

Transparency about lagging diversity numbers signals genuine progress.

Apfelbaum EP, Suh EY. Apfelbaum EP, et al. Among authors: suh ey. J Exp Psychol Gen. 2024 Jan;153(1):255-267. doi: 10.1037/xge0001489. Epub 2023 Sep 28. J Exp Psychol Gen. 2024. PMID: 37768576

2

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone.

Le TP, Yu Y, Cho IS, Suh EY, Kwon HC, Shin SA, Park YH, Huh KM. Le TP, et al. Among authors: suh ey. J Korean Med Sci. 2023 May 1;38(17):e135. doi: 10.3346/jkms.2023.38.e135. J Korean Med Sci. 2023. PMID: 37128878 Free PMC article.

3

Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.

Raskob GE, Ageno W, Albers G, Elliott CG, Halperin J, Maynard G, Steg PG, Weitz JI, Albanese J, Yuan Z, Levitan B, Lu W, Suh EY, Spiro T, Lipardi C, Barnathan ES, Spyropoulos AC. Raskob GE, et al. Among authors: suh ey. J Am Heart Assoc. 2022 Oct 18;11(20):e026229. doi: 10.1161/JAHA.122.026229. Epub 2022 Oct 7. J Am Heart Assoc. 2022. PMID: 36205248 Free PMC article. Clinical Trial.

4

Injectable glycol chitosan thermogel formulation for efficient inner ear drug delivery.

Yu Y, Kim DH, Suh EY, Jeong SH, Kwon HC, Le TP, Kim Y, Shin SA, Park YH, Huh KM. Yu Y, et al. Among authors: suh ey. Carbohydr Polym. 2022 Feb 15;278:118969. doi: 10.1016/j.carbpol.2021.118969. Epub 2021 Dec 9. Carbohydr Polym. 2022. PMID: 34973784

5

Non-cell adhesive hexanoyl glycol chitosan hydrogels for stable and efficient formation of 3D cell spheroids with tunable size and density.

Jang BS, Park KH, Suh EY, Lee BS, Kang SW, Huh KM. Jang BS, et al. Among authors: suh ey. Int J Biol Macromol. 2021 Sep 30;187:955-963. doi: 10.1016/j.ijbiomac.2021.07.185. Epub 2021 Jul 31. Int J Biol Macromol. 2021. PMID: 34343581

6

Endurance exercise training restores atrophy-induced decreases of myogenic response and ionic currents in rat skeletal muscle artery.

Yin MZ, Kim HJ, Suh EY, Zhang YH, Yoo HY, Kim SJ. Yin MZ, et al. Among authors: suh ey. J Appl Physiol (1985). 2019 Jun 1;126(6):1713-1724. doi: 10.1152/japplphysiol.00962.2018. Epub 2019 Mar 28. J Appl Physiol (1985). 2019. PMID: 30920885 Free article.

7

The cutting-edge technologies of siRNA delivery and their application in clinical trials.

Lee K, Jang B, Lee YR, Suh EY, Yoo JS, Lee MJ, Lee JY, Lee H. Lee K, et al. Among authors: suh ey. Arch Pharm Res. 2018 Sep;41(9):867-874. doi: 10.1007/s12272-018-1069-4. Epub 2018 Aug 22. Arch Pharm Res. 2018. PMID: 30136248 Review.

8

Maxi-K channel (BK_C_a) activity veils the myogenic tone of mesenteric artery in rats.

Suh EY, Yin MZ, Lin H, Zhang YH, Yoo HY, Kim SJ. Suh EY, et al. Physiol Rep. 2017 Jul;5(14):e13330. doi: 10.14814/phy2.13330. Physiol Rep. 2017. PMID: 28720714 Free PMC article.

9

The treatment of missing data in a large cardiovascular clinical outcomes study.

Little RJ, Wang J, Sun X, Tian H, Suh EY, Lee M, Sarich T, Oppenheimer L, Plotnikov A, Wittes J, Cook-Bruns N, Burton P, Gibson CM, Mohanty S. Little RJ, et al. Among authors: suh ey. Clin Trials. 2016 Jun;13(3):344-51. doi: 10.1177/1740774515626411. Epub 2016 Feb 17. Clin Trials. 2016. PMID: 26908543

10

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.

Raskob GE, Spyropoulos AC, Zrubek J, Ageno W, Albers G, Elliott CG, Halperin J, Haskell L, Hiatt WR, Maynard GA, Peters G, Spiro T, Steg PG, Suh EY, Weitz JI. Raskob GE, et al. Among authors: suh ey. Thromb Haemost. 2016 Jun 2;115(6):1240-8. doi: 10.1160/TH15-09-0756. Epub 2016 Feb 4. Thromb Haemost. 2016. PMID: 26842902 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page